WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ:TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that Alan A. Musso, Vice President and Chief Financial Officer, is scheduled to present at the “Newsmakers in the Biotech Industry” conference sponsored by BioCentury. The conference will be held on Thursday, September 6, 2007 at the Millennium Broadway Hotel & Conference Center in New York City. Mr. Musso will speak at 4:00 p.m. Eastern Daylight Time in Presentation Room 402/403.
